1800 244 735

Huntington’s Disease research update

Handwriting Can Help Identify Asymptomatic Huntington’s, Study Suggests.

WORDS Alberto Molano, PhD from Huntington’s Disease News

ANALYSIS OF handwriting movements using a pen tablet and specialised software can accurately distinguish  people with Huntington’s disease who are still asymptomatic from those without the disease, a new study suggests.

The findings also reveal that certain stroke  features  differ significantly between healthy individuals and patients who are already experiencing Huntington’s symptoms.

The research, “Handwriting Movement abnormalities in Symptomatic and premanifest huntington’s Disease,” was published in the journal Movement Disorders Clinical Practice.

Handwriting abnormalities in huntington’s patients were last reported nearly 20 years ago, and included longer stroke duration and greater variability in stroke velocity. among questions still unanswered is whether assessing handwriting movements can help detect abnormalities in the asymptomatic (premanifest) stage of Huntington’s and serve as a predictor of disease progression.

To investigate, researchers at university of California San Diego test- ed whether handwriting abnormalities were associated with clinical features in symptomatic patients, and if such abnormalities could distinguish asymptomatic Huntington’s patients from healthy controls.

The team asked participants to complete five simple tasks: draw simple loops left to right (a string of “l” letters in cursive writing), complex loops (“lleel- lee”), rapid overlay circles, and spirals, and write the  sentence “today is a nice day.”

Participants used a Wacom digitizing  tablet,  a  device  often used by artists to draw on a computer  screen.  the  tablet  has  a special pen and is sensitive to the level of applied pressure, mimicking traditional drawing on paper. Handwriting traces were recorded and analyzed using a specialized software called MovAlyzeR.

The study involved 38 symptomatic patients (mean age of 55 years), 30 asymptomatic individuals at risk for symptomatic disease (45 years), and 25 healthy controls (44 years).

Results revealed significantly longer and more variable stroke du- ration, as well as decreased hand- writing smoothness, and increased and more variable pen pressures in the handwriting of Huntington’s patients compared with the handwriting of the healthy controls.

Longer stroke duration was associated with greater penney burden of pathology (BOP) and CAG × age product, two measures of disease progression. Of note, the CAG × age product is calculated by multiplying the number of CAG repeats by the patient’s age.

CAG repeats are the genetic abnormality in people with huntington’s. Patients may have 36 to more than 120 of these repeats of three DNA building blocks (cytosine, adenine, and guanine) in their HTT gene. The longer this region is, the earlier the symptoms appear and the more severe the disease.

Handwriting abnormalities in Huntington’s patients were last reported nearly 20 years ago...

Data also showed that analysis of certain handwriting features could distinguish asymptomatic patients from controls with 85% accuracy, 90% sensitivity, and 80% specificity. these included greater variability in stroke amplitude, velocity and pen pressure, higher levels of pen pressure, longer stroke durations, and lower velocities for combinations of handwritten circles, sentences, and spirals.

“These findings support the clinical utility of dynamic measures of hand- writing kinematics as a potential early behavioral biomarker in [huntington’s],” the researchers wrote.

However, they cautioned that these results require confirmation, especially those in asymptomatic patients, and that studies in larger groups are still needed.

Latest Research Articles

Cry your eyes out: detecting huntingtin in tears

Published date: 10 April, 2024

A recently published collaboration between academic researchers and pharmaceutical companies was successful at detecting huntingtin in tears. The scientists were looking for a new, easy way to track Huntington’s disease (HD). If you don’t mind shedding a tear or two, they found it! Biomarkers – biological metrics in tune with disease progression Tracking disease progression ... Read more

The director’s cut: how CAG repeats change the editing of genetic messages

Published date: 26 March, 2024

Long repetitive sequences of C-A-G letters in the DNA code are associated with at least 12 genetic diseases, including Huntington’s disease (HD). A group of scientists in Massachusetts, USA, have recently developed a new genetic strategy to study how CAG repeats can lead to harmful proteins being made in cells, causing cells to become unhealthy. ... Read more

Understanding expansions at the single cell level

Published date: 12 March, 2024

In two recent studies, researchers looked at how different parts of the brain are affected by CAG expansions in Huntington’s disease (HD) at the level of individual brain cells. The scientists looked at post-mortem brains from people with and without HD to track molecular changes in different brain regions called the cortex and striatum. These ... Read more

Huntington's Disease Therapeutics Conference 2024 – Day 3

Published date: 7 March, 2024

HDBuzz is back for the last day of the CHDI HD Therapeutics Conference: Thursday February 29th in Palm Springs, California. This article summarizes our real-time updates of the conference in community-friendly language. From genes to medicines The morning session will focus on how human genetics is driving the development of therapeutics. “Genetic modifiers” are genes ... Read more

Huntington's Disease Therapeutics Conference 2024 – Day 2

Published date: 6 March, 2024

HDBuzz is back for Day 2 of the CHDI HD Therapeutics Conference: Wednesday February 28th in Palm Springs, California. This article summarizes our real-time updates of the conference in community-friendly language. It’s a brain disease This morning’s session is titled “It’s a brain disease” and will feature talks about BRAINSSSS! HD scientists are a bit ... Read more

Huntington's Disease Therapeutics Conference 2024 – Day 1

Published date: 5 March, 2024

The HDBuzz team recently convened in Palm Springs, California, along with hundreds of other scientists from all over the globe, for the 19th Annual HD Therapeutics Conference, hosted by the HD research foundation CHDI. From Tuesday February 27th through Thursday February 29th, we live-tweeted dozens of scientific talks by world experts in Huntington’s disease research, ... Read more